Develops next-generation antibodies into transformative cancer therapies targeting the tumor microenvironment.[1]
Get notified the moment Compass Therapeutics files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.